Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy
Timely treatment with rifaximin in adherence with clinical practice guidelines following an initial OHE hospitalization was associated with improved short-term and longer-term rehospitalization outcomes, regardless of insurance type.
Authors
- Olamide Olujohungbe
- Remi Bellefleur (ORCID: https://orcid.org/0000-0001-9540-9519)
- Arun Jesudian (ORCID: https://orcid.org/0000-0002-8562-3375)
- A. Guérin
- Rebecca Bungay (ORCID: https://orcid.org/0000-0001-7235-3292)
- Patrick Gagnon‐Sanschagrin (ORCID: https://orcid.org/0000-0002-3582-9447)
- Kaitlyn Easson
- Shweta Kiran Shah
Institutions
- Cornell University (US)
- Bausch Health (United States) (US)
- Group for Research in Decision Analysis (CA)
- Weill Cornell Medicine (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1097/hc9.0000000000000874
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00